English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Injecting drug use is strongly associated with severe health problems in drug users, including bloodborne infections (e.g. HIV/AIDS, hepatitis) and overdose. According to the annual report of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), published on 10 November, the latest data from treatment monitoring are encouraging, showing a stable to downward trend in drug injecting. Among heroin users entering treatment, a decline in the proportion of injectors was reported in 13 countries between 2002 and 2007. The latest data show that under half (42%) of those entering treatment for primary opioid use in Europe report ‘usually injecting’ their drug, while the proportion for those entering for the first time is lower (38%) [1].

The EMCDDA annual report 2010: the state of the drugs problem in Europe